Xiao-Jia Wang

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Xi-Chun Hu, Jian Zhang, Bing-He Xu et al. · The Lancet Oncology · 2015 · 279 citations

First-line Therapy, Breast Oncology, Oncology +7

A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer

Ke‐Da Yu, Ying Zhou, Guang‐Yu Liu et al. · Breast Cancer Research and Treatment · 2012 · 49 citations

Nursing, Breast Oncology, Medicine +13

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer

Wen‐Ming Cao, Yun Gao, Hong-Jian Yang et al. · BMC Cancer · 2016 · 33 citations · Full text

Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women

Wen‐Ming Cao, Ya-Bing Zheng, Yun Gao et al. · BMC Cancer · 2019 · 31 citations · Full text

The effect of palonosetron hydrochloride in the prevention of chemotherapy-induced moderate and severe nausea and vomiting

Jian Huang, Xiao-Jia Wang, Yu Ding et al. · Experimental and Therapeutic Medicine · 2013 · 19 citations · Full text

Drug Safety, Adverse Events, Current Study +13